Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma: A pharmacokinetic–pharmacodynamic analysis from the IELSG no. 20 trial
Markus Joerger, A. D. Huitema, Stephan Krähenbühl, J. Schellens, J. Schellens, Thomas Cerny, Michele Reni, Emanuele Zucca, F. Cavalli, Andrés José Maria Ferreri
British Journal of Cancer